The Biohaven Pharmaceutical brand, founded in 2013 (United States), from 2214 competing brands. Biohaven Pharmaceutical is owned by Biohaven Pharmaceutical Holding Company Ltd., listed on the stock exchange of New York The ISIN, the company's International Securities Identification Number, is VGG111961055. Biohaven Pharmaceutical is part of the Biotechnology activity sector.